Retinal Optical Coherence Tomography in Neuromyelitis Optica
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Abstract
Background and Objectives To determine optic nerve and retinal damage in aquaporin-4 antibody (AQP4-IgG)-seropositive neuromyelitis optica spectrum disorders (NMOSD) in a large international cohort after previous studies have been limited by small and heterogeneous cohorts.
Methods The cross-sectional Collaborative Retrospective Study on retinal optical coherence tomography (OCT) in neuromyelitis optica collected retrospective data from 22 centers. Of 653 screened participants, we included 283 AQP4-IgG–seropositive patients with NMOSD and 72 healthy controls (HCs). Participants underwent OCT with central reading including quality control and intraretinal segmentation. The primary outcome was thickness of combined ganglion cell and inner plexiform (GCIP) layer; secondary outcomes were thickness of peripapillary retinal nerve fiber layer (pRNFL) and visual acuity (VA).
Results Eyes with ON (NMOSD-ON, N = 260) or without ON (NMOSD-NON, N = 241) were assessed compared with HCs (N = 136). In NMOSD-ON, GCIP layer (57.4 ± 12.2 μm) was reduced compared with HC (GCIP layer: 81.4 ± 5.7 μm, p < 0.001). GCIP layer loss (−22.7 μm) after the first ON was higher than after the next (−3.5 μm) and subsequent episodes. pRNFL observations were similar. NMOSD-NON exhibited reduced GCIP layer but not pRNFL compared with HC. VA was greatly reduced in NMOSD-ON compared with HC eyes, but did not differ between NMOSD-NON and HC.
Discussion Our results emphasize that attack prevention is key to avoid severe neuroaxonal damage and vision loss caused by ON in NMOSD. Therapies ameliorating attack-related damage, especially during a first attack, are an unmet clinical need. Mild signs of neuroaxonal changes without apparent vision loss in ON-unaffected eyes might be solely due to contralateral ON attacks and do not suggest clinically relevant progression but need further investigation.
Glossary
- AQP4-IgG=
- aquaporin-4 IgG;
- CROCTINO=
- Collaborative Retrospective Study on retinal OCT in Neuromyelitis Optica;
- EDSS=
- Expanded Disability Status Scale;
- GCIP=
- ganglion cell and inner plexiform;
- HC=
- healthy control;
- HC-VA=
- high-contrast visual acuity;
- INL=
- inner nuclear layer;
- MME=
- microcystic macular edema;
- MS=
- multiple sclerosis;
- MOG-IgG=
- myelin oligodendrocyte glycoprotein IgG;
- NMOSD=
- neuromyelitis optica spectrum disorder;
- NMOSD-NON=
- NMOSD eyes without a history of ON;
- OCT=
- optical coherence tomography;
- ON=
- optic neuritis;
- pRNFL=
- peripapillary retinal nerve fiber layer;
- SE=
- standard error;
- VA=
- visual acuity;
- VEP=
- visually evoked potential
Footnotes
Go to Neurology.org/NN for full disclosures. Funding information is provided at the end of the article.
↵* These authors contributed equally to this work.
The Article Processing Charge was funded by the authors.
- Received March 23, 2021.
- Accepted in final form June 15, 2021.
- Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaElias S. Sotirchos, Shiv Saidha, Gita Byraiah et al.Neurology, March 20, 2013 -
Article
Bilateral retinal pathology following a first-ever clinical episode of autoimmune optic neuritisCarla A. Wicki, Praveena Manogaran, Tanja Simic et al.Neurology: Neuroimmunology & Neuroinflammation, January 22, 2020 -
Article
Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disordersSeyedamirhosein Motamedi, Frederike C. Oertel, Sunil K. Yadav et al.Neurology: Neuroimmunology & Neuroinflammation, June 23, 2020 -
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007